BICLUSTER_ID : UPREG-132
PATHOGENS /3/ : brucella neotomae,listeria monocytogenes,streptococcus pneumoniae
TARGETS /9/ : NFKB1, STAT1, PPARD, CCL8, PSMD1, IL6, AMPD3, PTGS2, PIM1
Gene SetLeading Edge Genes
NETPATH IL 1 PATHWAY UPNFKB1, CCL8, HBEGF, CKS2, NFKBIA, IL6, AMPD3, PTGS2, MT2A, ZFP36, PSMA3, INHBA, CXCL2, SOD2
NETPATH IL 6 PATHWAY UPSTAT1, GADD45B, PPARD, HBEGF, NMI, ZFP36, PIM1, EIF5
NETPATH IL 1 PATHWAYNFKB1, NFKBIA, IL1RN, PELI1
NCI VIF MEDIATED DEGRADATION OF APOBEC3GPSMD7, PSMA5, TCEB1, PSMA2, PSMD1, PSMC1, PSMB7, PSMA3, PSMA7, PSMD14, PSMA1, PSMA6, PSMD6, PSMD12, PSMB3, PSMC6
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
CHEN LVAD SUPPORT OF FAILING HEART UP
NCI TNFPATHWAY
OUELLET OVARIAN CANCER INVASIVE VS LMP UP
SANA RESPONSE TO IFNG DN
LINDSTEDT DENDRITIC CELL MATURATION B
LY AGING OLD DN
NCI HOST INTERACTIONS OF HIV FACTORS
LINDSTEDT DENDRITIC CELL MATURATION A
ELVIDGE HYPOXIA UP
SESTO RESPONSE TO UV C0
AMIT EGF RESPONSE 40 HELA
NETPATH IL 7 PATHWAY UP
REACTOME SCF SKP2 MEDIATED DEGRADATION OF P27 P21
NCI SCF SKP2 MEDIATED DEGRADATION OF P27 P21
BROWNE INTERFERON RESPONSIVE GENES
HEDVAT ELF4 TARGETS UP
RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
HASINA NOL7 TARGETS UP
REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1
CORUM PA700 COMPLEX
NUYTTEN NIPP1 TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
HINATA NFKB TARGETS KERATINOCYTE UP
CORUM PA28GAMMA-20S PROTEASOME
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
AMIT SERUM RESPONSE 60 MCF10A
DUTTA APOPTOSIS VIA NFKB
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
DIRMEIER LMP1 RESPONSE EARLY
NCI APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1PSMA6, PSMA1, PSMD14, PSMD6, PSMD12, PSMA5, PSMA2, PSMC1, PSMB7, PSMB3, PSMA3, PSMA7, UBE2E1, PSMC6
NCI VPU MEDIATED DEGRADATION OF CD4
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION MONOCYTE UP
NCI AUTODEGRADATION OF CDH1 BY CDH1 APC CPSMA6, PSMA1, PSMD14, PSMD6, PSMD12, PSMA5, PSMA2, PSMC1, PSMB7, PSMB3, PSMA3, PSMA7, UBE2E1, PSMC6
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
AMIT EGF RESPONSE 120 HELA
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 11
REACTOME ELECTRON TRANSPORT CHAIN
SEIDEN ONCOGENESIS BY MET
REACTOME APOPTOSIS
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
NCI CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6
NETPATH TNF ALPHA PATHWAY
GAJATE RESPONSE TO TRABECTEDIN UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
FOSTER INFLAMMATORY RESPONSE LPS DN
TAVOR CEBPA TARGETS UP
WANG SMARCE1 TARGETS DN
REACTOME P53 INDEPENDENT DNA DAMAGE RESPONSE
HELLER SILENCED BY METHYLATION UP
GARY CD5 TARGETS DN
NCI CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
NETPATH TNF ALPHA PATHWAY UP
WOOD EBV EBNA1 TARGETS DN
TOOKER GEMCITABINE RESISTANCE DN
WINTER HYPOXIA UP
GRADE COLON AND RECTAL CANCER UP
AMIT SERUM RESPONSE 120 MCF10A
PELLICCIOTTA HDAC IN ANTIGEN PRESENTATION UP
VANTVEER BREAST CANCER ESR1 DN
BERENJENO TRANSFORMED BY RHOA UP
REACTOME REGULATION OF ORNITHINE DECARBOXYLASE
PUIFFE INVASION INHIBITED BY ASCITES DN
SESTO RESPONSE TO UV C3
CORUM PA700-20S-PA28 COMPLEXPSMA6, PSMA1, PSMD14, PSMD6, PSMD12, PSMA2, PSMA5, PSMC1, PSMB7, PSMB3, PSMA3, PSMC6, PSMA7
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
GERY CEBP TARGETS
CORUM SPLICEOSOME
TIAN TNF SIGNALING VIA NFKB
ZHANG PROLIFERATING VS QUIESCENT
HUMMEL BURKITTS LYMPHOMA DN
NCI SCF BETA TRCP MEDIATED DEGRADATION OF EMI1PSMA6, PSMA1, PSMD14, PSMD6, PSMD12, PSMA5, PSMA2, PSMC1, PSMB7, PSMB3, PSMA3, PSMC6, PSMA7
KEGG PROTEASOME
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION1PSMA6, PSMA1, PSMD14, PSMD6, PSMD12, PSMA5, PSMA2, PSMC1, PSMB7, PSMB3, PSMA3, PSMC6, PSMA7
LEE LIVER CANCER HEPATOBLAST
NCI DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX
NAGASHIMA EGF SIGNALING UP
WONG PROTEASOME GENE MODULE
WAMUNYOKOLI OVARIAN CANCER GRADES 1 2 UP
BENPORATH PROLIFERATION
AMIT EGF RESPONSE 60 MCF10A
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
CHEN HOXA5 TARGETS 6HR UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
LEONARD HYPOXIA
NELSON RESPONSE TO ANDROGEN UP
TARTE PLASMA CELL VS PLASMABLAST DN
SESTO RESPONSE TO UV C1
CROONQUIST STROMAL STIMULATION UP
DAZARD RESPONSE TO UV SCC UP
HALMOS CEBPA TARGETS UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 10
NCI APC C CDC20 MEDIATED DEGRADATION OF SECURINPSMA6, PSMA1, PSMD14, PSMD6, PSMD12, PSMA5, PSMA2, PSMC1, PSMB7, PSMB3, PSMA3, PSMC2, PSMA7, UBE2E1, PSMC6
SHAFFER IRF4 TARGETS IN MYELOMA VS MATURE B LYMPHOCYTE
BROWNE HCMV INFECTION 2HR DN
CORUM PA28-20S PROTEASOME
MAHADEVAN RESPONSE TO MP470 DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
HARRIS HYPOXIA
DER IFN BETA RESPONSE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
DIRMEIER LMP1 RESPONSE LATE UP
BASSO CD40 SIGNALING UP
KAN RESPONSE TO ARSENIC TRIOXIDE
BIOCARTA NTHI PATHWAY
TIAN TNF SIGNALING NOT VIA NFKB
SOUCEK MYC TARGETS
MARZEC IL2 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
BIOCARTA PPARA PATHWAY
SCHLOSSER SERUM RESPONSE DN
BILBAN B CLL LPL DN
REACTOME HIV INFECTION
GOLDRATH ANTIGEN RESPONSE
FERRARI RESPONSE TO FENRETINIDE UP
NAKAMURA TUMOR ZONE PERIPHERAL VS CENTRAL UP
REACTOME REGULATION OF APC ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE
REACTOME CDC20 PHOSPHO APC MEDIATED DEGRADATION OF CYCLIN A
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
MARTINEZ RESPONSE TO TRABECTEDIN UP
MENSE HYPOXIA UPHK2, ATF3, ADM, TIPARP
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
PELLICCIOTTA HDAC IN ANTIGEN PRESENTATION DN
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
SMITH TERT TARGETS UP
NETPATH IL 5 PATHWAY UP
RORIE TARGETS OF EWSR1 FLI1 FUSION UP
WANG RECURRENT LIVER CANCER DN
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
SANA TNF SIGNALING UP
SAKAI TUMOR INFILTRATING MONOCYTES DN
NCI UBIQUITIN DEPENDENT DEGRADATION OF CYCLIN D1PSMA6, PSMA1, PSMD14, PSMD6, PSMD12, PSMA5, PSMA2, PSMC1, PSMB7, PSMB3, PSMA3, PSMC6, PSMA7
NCI CDC20 PHOSPHO APC C MEDIATED DEGRADATION OF CYCLIN APSMA1, PSMA6, PSMD14, PSMD6, PSMD12, PSMA5, PSMA2, PSMC1, PSMB7, PSMB3, PSMA3, PSMC2, PSMA7, UBE2E1, PSMC6
CORUM 20S PROTEASOME
NCI REGULATION OF ORNITHINE DECARBOXYLASE ODC
CORUM 26S PROTEASOME
REACTOME SIGNALING BY WNT
REACTOME STABILIZATION OF P53
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
WEST ADRENOCORTICAL TUMOR UP
MILI PSEUDOPODIA HAPTOTAXIS UP
KIM WT1 TARGETS UP
SHAFFER IRF4 TARGETS IN ACTIVATED B LYMPHOCYTE
REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC
VECCHI GASTRIC CANCER ADVANCED VS EARLY UP
ONDER CDH1 TARGETS 1 DN
NETPATH ANDROGEN RECEPTOR PATHWAY UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 48HR UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
DASU IL6 SIGNALING UP
ELVIDGE HYPOXIA BY DMOG UP
NETPATH IL 2 PATHWAY UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
NCI SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE
ZUCCHI METASTASIS DN
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATIONPSMA6, PSMA1, PSMD14, PSMD6, PSMD12, PSMA5, PSMA2, PSMC1, PSMB7, PSMB3, PSMA3, PSMC6, PSMA7
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 7
NCI UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25APSMA6, PSMA1, PSMD14, PSMD6, PSMD12, PSMA5, PSMA2, PSMC1, PSMB7, PSMB3, PSMA3, PSMC6, PSMA7
PRAMOONJAGO SOX4 TARGETS UP
TOOKER RESPONSE TO BEXAROTENE UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
KIM WT1 TARGETS 8HR UP
REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION
TIEN INTESTINE PROBIOTICS 6HR DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
streptococcus pneumoniae g54listeria monocytogenesbrucella neotomaeGeneSet Name
0.02186 0.00000 0.00114NETPATH_IL_1_PATHWAY_UP
0.01842 0.00233 0.01660NETPATH_IL_6_PATHWAY_UP
0.03624 0.00142 0.10960NETPATH_IL_1_PATHWAY
0.03365 0.00069 0.00197NCI_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.03257 0.00023 0.03682GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.08911 0.00046 0.16767MAHAJAN_RESPONSE_TO_IL1A_UP
0.00875 0.01186 0.18229WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.01145 0.06346 0.12942CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.16078 0.03361 0.15376NCI_TNFPATHWAY
0.00673 0.00023 0.00560OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
0.07626 0.06840 0.13440SANA_RESPONSE_TO_IFNG_DN
0.00817 0.00437 0.02410LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.19137 0.09782 0.02651LY_AGING_OLD_DN
0.04816 0.00045 0.00221NCI_HOST_INTERACTIONS_OF_HIV_FACTORS
0.16372 0.00000 0.00010LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00034 0.00023 0.04424ELVIDGE_HYPOXIA_UP
0.00808 0.00001 0.15613SESTO_RESPONSE_TO_UV_C0
0.02615 0.00068 0.01260AMIT_EGF_RESPONSE_40_HELA
0.11486 0.09197 0.01290NETPATH_IL_7_PATHWAY_UP
0.09247 0.00028 0.00119REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.08690 0.00110 0.00381NCI_SCF_SKP2__MEDIATED_DEGRADATION_OF_P27_P21
0.11107 0.00000 0.00715BROWNE_INTERFERON_RESPONSIVE_GENES
0.16616 0.06267 0.19025HEDVAT_ELF4_TARGETS_UP
0.02406 0.10972 0.14910RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
0.09013 0.00000 0.01038THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.11236 0.00843 0.13868HASINA_NOL7_TARGETS_UP
0.05313 0.00013 0.00216REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.07455 0.01626 0.01910CORUM_PA700_COMPLEX
0.00315 0.00090 0.03667NUYTTEN_NIPP1_TARGETS_UP
0.14828 0.00030 0.16364TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00568 0.00001 0.09086HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.11893 0.00011 0.00385CORUM_PA28GAMMA-20S_PROTEASOME
0.17463 0.00736 0.00378KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00321 0.02234 0.11766AMIT_SERUM_RESPONSE_60_MCF10A
0.05455 0.01422 0.00644DUTTA_APOPTOSIS_VIA_NFKB
0.00641 0.03942 0.11146COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.08905 0.00199 0.00214DIRMEIER_LMP1_RESPONSE_EARLY
0.04220 0.00178 0.00390NCI_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1
0.07354 0.00119 0.00369NCI_VPU_MEDIATED_DEGRADATION_OF_CD4
0.09373 0.02666 0.11319TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.04350 0.00143 0.00352NCI_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C
0.11282 0.00000 0.01309ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.03102 0.00011 0.01819ONDER_CDH1_TARGETS_3_DN
0.01216 0.00000 0.01477GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.01466 0.02592 0.02726AMIT_EGF_RESPONSE_120_HELA
0.05311 0.17030 0.07252YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11
0.02389 0.14708 0.14327REACTOME_ELECTRON_TRANSPORT_CHAIN
0.02167 0.05109 0.15097SEIDEN_ONCOGENESIS_BY_MET
0.15199 0.00088 0.11007REACTOME_APOPTOSIS
0.13119 0.01127 0.19381NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.15941 0.00070 0.00247NCI_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6
0.02401 0.08032 0.08966NETPATH_TNF_ALPHA_PATHWAY
0.00696 0.01700 0.10625GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.03041 0.01078 0.13954SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.01680 0.00001 0.00621FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.04868 0.00125 0.11809TAVOR_CEBPA_TARGETS_UP
0.03606 0.04978 0.00214WANG_SMARCE1_TARGETS_DN
0.05824 0.00031 0.00150REACTOME_P53_INDEPENDENT_DNA_DAMAGE_RESPONSE
0.17361 0.07324 0.10277HELLER_SILENCED_BY_METHYLATION_UP
0.04084 0.02851 0.04542GARY_CD5_TARGETS_DN
0.15800 0.01511 0.00929NCI_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX
0.02405 0.03199 0.03432SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.07319 0.00123 0.10261NETPATH_TNF_ALPHA_PATHWAY_UP
0.04965 0.00309 0.13104WOOD_EBV_EBNA1_TARGETS_DN
0.00040 0.01807 0.11559TOOKER_GEMCITABINE_RESISTANCE_DN
0.01824 0.00203 0.08089WINTER_HYPOXIA_UP
0.03050 0.01729 0.17562GRADE_COLON_AND_RECTAL_CANCER_UP
0.00320 0.00040 0.11404AMIT_SERUM_RESPONSE_120_MCF10A
0.14609 0.09048 0.14885PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP
0.05316 0.02711 0.14884VANTVEER_BREAST_CANCER_ESR1_DN
0.09492 0.13680 0.00234BERENJENO_TRANSFORMED_BY_RHOA_UP
0.11131 0.00069 0.00938REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE
0.00111 0.00272 0.06347PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.01104 0.00002 0.04591SESTO_RESPONSE_TO_UV_C3
0.04807 0.00011 0.00108CORUM_PA700-20S-PA28_COMPLEX
0.12533 0.00000 0.03242VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.09635 0.00001 0.11642BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.03258 0.00027 0.01183GEISS_RESPONSE_TO_DSRNA_UP
0.03598 0.00032 0.16491GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.12493 0.00163 0.18522GERY_CEBP_TARGETS
0.17955 0.10949 0.07834CORUM_SPLICEOSOME
0.16057 0.00054 0.05899TIAN_TNF_SIGNALING_VIA_NFKB
0.14796 0.12224 0.14382ZHANG_PROLIFERATING_VS_QUIESCENT
0.05491 0.17259 0.07619HUMMEL_BURKITTS_LYMPHOMA_DN
0.03767 0.00045 0.00384NCI_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.05741 0.00038 0.00158KEGG_PROTEASOME
0.04333 0.00062 0.00256NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION1
0.06587 0.02848 0.17189LEE_LIVER_CANCER_HEPATOBLAST
0.05961 0.00037 0.00597NCI_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX
0.00045 0.00001 0.01336NAGASHIMA_EGF_SIGNALING_UP
0.05051 0.11747 0.05629WONG_PROTEASOME_GENE_MODULE
0.00335 0.10776 0.02237WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP
0.04449 0.15003 0.04383BENPORATH_PROLIFERATION
0.00090 0.01523 0.02489AMIT_EGF_RESPONSE_60_MCF10A
0.00034 0.00002 0.17807CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.01846 0.00069 0.12949CHEN_HOXA5_TARGETS_6HR_UP
0.01878 0.00001 0.00128OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.00548 0.00328 0.16786LEONARD_HYPOXIA
0.00703 0.02410 0.04612NELSON_RESPONSE_TO_ANDROGEN_UP
0.07883 0.05684 0.00389TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
0.00828 0.00001 0.03217SESTO_RESPONSE_TO_UV_C1
0.09861 0.05925 0.00132CROONQUIST_STROMAL_STIMULATION_UP
0.01405 0.04954 0.00474DAZARD_RESPONSE_TO_UV_SCC_UP
0.02527 0.01542 0.07569HALMOS_CEBPA_TARGETS_UP
0.04938 0.15030 0.10254YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10
0.04423 0.00482 0.00375NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_SECURIN
0.02411 0.06270 0.11444SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE
0.09008 0.05613 0.07644BROWNE_HCMV_INFECTION_2HR_DN
0.08304 0.00254 0.00236CORUM_PA28-20S_PROTEASOME
0.15502 0.01146 0.00665MAHADEVAN_RESPONSE_TO_MP470_DN
0.08161 0.00000 0.02175TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.10031 0.00000 0.17495HARRIS_HYPOXIA
0.11870 0.00000 0.05335DER_IFN_BETA_RESPONSE_UP
0.07134 0.00166 0.06990GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.01803 0.00000 0.05608DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.06964 0.12444 0.16770DIRMEIER_LMP1_RESPONSE_LATE_UP
0.03498 0.00020 0.03927BASSO_CD40_SIGNALING_UP
0.04440 0.00399 0.18328KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.04158 0.03739 0.17996BIOCARTA_NTHI_PATHWAY
0.00388 0.01298 0.11317TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.08229 0.09270 0.01093SOUCEK_MYC_TARGETS
0.16651 0.00507 0.08610MARZEC_IL2_SIGNALING_UP
0.00022 0.00045 0.06679NAGASHIMA_NRG1_SIGNALING_UP
0.18979 0.13158 0.14321BIOCARTA_PPARA_PATHWAY
0.00395 0.02650 0.15917SCHLOSSER_SERUM_RESPONSE_DN
0.05066 0.01132 0.03678BILBAN_B_CLL_LPL_DN
0.13830 0.16707 0.10983REACTOME_HIV_INFECTION
0.18885 0.04561 0.02834GOLDRATH_ANTIGEN_RESPONSE
0.01205 0.06128 0.02413FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.03096 0.13450 0.11243NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
0.04326 0.00054 0.00384REACTOME_REGULATION_OF_APC_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE
0.03006 0.00091 0.00239REACTOME_CDC20_PHOSPHO_APC_MEDIATED_DEGRADATION_OF_CYCLIN_A
0.01216 0.00001 0.01035LIANG_SILENCED_BY_METHYLATION_2
0.03237 0.00016 0.00155DAUER_STAT3_TARGETS_UP
0.05320 0.00069 0.00129REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.02602 0.05104 0.04575ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.05063 0.00555 0.10684MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.00004 0.01410 0.06879MENSE_HYPOXIA_UP
0.02905 0.02795 0.04600AMIT_EGF_RESPONSE_60_HELA
0.09462 0.03814 0.09764ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.04093 0.00306 0.00660PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.00050 0.00000 0.02011CHEN_HOXA5_TARGETS_9HR_UP
0.03619 0.04745 0.00657DAZARD_UV_RESPONSE_CLUSTER_G2
0.00324 0.03609 0.00622SMITH_TERT_TARGETS_UP
0.07746 0.00007 0.12369NETPATH_IL_5_PATHWAY_UP
0.04298 0.00899 0.02214RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.05148 0.03753 0.07016WANG_RECURRENT_LIVER_CANCER_DN
0.00737 0.00799 0.03264AMIT_SERUM_RESPONSE_40_MCF10A
0.02093 0.00000 0.00041SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.11160 0.00097 0.07552GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00231 0.00000 0.00387ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.15203 0.00000 0.00058SANA_TNF_SIGNALING_UP
0.09382 0.06132 0.14409SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN
0.04818 0.00081 0.00204NCI_UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D1
0.02613 0.00272 0.00500NCI_CDC20_PHOSPHO_APC_C_MEDIATED_DEGRADATION_OF_CYCLIN_A
0.11176 0.00025 0.00472CORUM_20S_PROTEASOME
0.05117 0.00061 0.00259NCI_REGULATION_OF_ORNITHINE_DECARBOXYLASE__ODC_
0.07300 0.00002 0.00147CORUM_26S_PROTEASOME
0.07740 0.00029 0.01155REACTOME_SIGNALING_BY_WNT
0.13021 0.00163 0.00387REACTOME_STABILIZATION_OF_P53
0.00067 0.00000 0.00059HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.02413 0.10836 0.06928WEST_ADRENOCORTICAL_TUMOR_UP
0.00277 0.04943 0.00513MILI_PSEUDOPODIA_HAPTOTAXIS_UP
0.00273 0.01564 0.10627KIM_WT1_TARGETS_UP
0.03773 0.18617 0.01082SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.05319 0.00111 0.00237REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC
0.01922 0.00309 0.09968VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.07758 0.00003 0.17331ONDER_CDH1_TARGETS_1_DN
0.00513 0.03984 0.13449NETPATH_ANDROGEN_RECEPTOR_PATHWAY_UP
0.00000 0.00007 0.00256UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.08775 0.00850 0.10373XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.13868 0.00001 0.15914HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.09369 0.00595 0.12777DASU_IL6_SIGNALING_UP
0.00018 0.00142 0.11243ELVIDGE_HYPOXIA_BY_DMOG_UP
0.16635 0.00068 0.17779NETPATH_IL_2_PATHWAY_UP
0.03864 0.00001 0.00010GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.01851 0.00001 0.00123OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.09866 0.01012 0.00424NCI_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE
0.01824 0.00518 0.01371ZUCCHI_METASTASIS_DN
0.04796 0.00056 0.00221NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION
0.05449 0.09654 0.07244YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7
0.04458 0.00046 0.00234NCI_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A
0.00000 0.01526 0.10655PRAMOONJAGO_SOX4_TARGETS_UP
0.00043 0.01784 0.11372TOOKER_RESPONSE_TO_BEXAROTENE_UP
0.00267 0.00887 0.16797PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.01014 0.00699 0.15073KIM_WT1_TARGETS_8HR_UP
0.06251 0.00007 0.00372REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
0.00052 0.07087 0.08251TIEN_INTESTINE_PROBIOTICS_6HR_DN